Imax Analyst Ratings
Imax Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/05/2022 | 29.65% | B. Riley Securities | $20 → $23 | Maintains | Buy |
| 11/01/2022 | -9.81% | JP Morgan | $18 → $16 | Maintains | Neutral |
| 11/01/2022 | 18.38% | Wells Fargo | $26 → $21 | Maintains | Overweight |
| 10/10/2022 | 1.47% | JP Morgan | $19 → $18 | Maintains | Neutral |
| 10/06/2022 | 18.38% | Benchmark | $25 → $21 | Maintains | Buy |
| 07/18/2022 | 40.92% | Benchmark | $28 → $25 | Maintains | Buy |
| 06/21/2022 | 40.92% | B. Riley Securities | $30 → $25 | Maintains | Buy |
| 05/24/2022 | 40.92% | Rosenblatt | → $25 | Initiates Coverage On | → Buy |
| 04/29/2022 | 29.65% | MKM Partners | $25 → $23 | Maintains | Buy |
| 10/22/2021 | 52.2% | Wells Fargo | → $27 | Initiates Coverage On | → Overweight |
| 06/02/2021 | 4.85% | Goldman Sachs | $19.6 → $18.6 | Downgrades | Neutral → Sell |
| 04/23/2021 | 46.56% | Wedbush | $22 → $26 | Upgrades | Neutral → Outperform |
| 02/01/2021 | 40.92% | MKM Partners | $18 → $25 | Maintains | Buy |
| 01/25/2021 | 0.9% | Goldman Sachs | $15.6 → $17.9 | Downgrades | Buy → Neutral |
| 07/13/2020 | 1.47% | MKM Partners | $20 → $18 | Maintains | Buy |
| 04/28/2020 | -21.08% | Benchmark | → $14 | Upgrades | Hold → Buy |
| 04/24/2020 | -32.36% | Wedbush | $25 → $12 | Downgrades | Outperform → Neutral |
| 04/15/2020 | 12.74% | MKM Partners | $24 → $20 | Maintains | Buy |
| 03/18/2020 | 7.1% | B. Riley Securities | $26 → $19 | Maintains | Buy |
| 03/17/2020 | — | Benchmark | Downgrades | Buy → Hold | |
| 03/17/2020 | -15.45% | JP Morgan | $22 → $15 | Downgrades | Overweight → Neutral |
| 02/20/2020 | 40.92% | Wedbush | $22 → $25 | Maintains | Outperform |
| 02/13/2020 | 46.56% | B. Riley Securities | $30 → $26 | Reiterates | → Buy |
| 02/03/2020 | 24.01% | Wedbush | $28 → $22 | Maintains | Outperform |
| 01/29/2020 | 12.74% | Benchmark | $28 → $20 | Maintains | Buy |
| 11/01/2019 | — | Canaccord Genuity | Upgrades | Hold → Buy | |
| 02/25/2019 | — | Canaccord Genuity | Downgrades | Buy → Hold | |
| 10/26/2018 | 29.65% | Canaccord Genuity | $26 → $23 | Maintains | Buy |
| 05/02/2018 | 91.66% | B. Riley Securities | $37.75 → $34 | Maintains | Buy |
| 04/27/2018 | — | Benchmark | Upgrades | Hold → Buy | |
| 02/28/2018 | 112.8% | B. Riley Securities | $35 → $37.75 | Maintains | Buy |
| 02/28/2018 | — | Roth Capital | Downgrades | Buy → Neutral | |
| 02/20/2018 | 57.84% | JP Morgan | $27 → $28 | Maintains | Overweight |
| 02/20/2018 | 57.84% | JP Morgan | → $28 | Assumes | Overweight → Overweight |
| 01/10/2018 | — | Piper Sandler | Downgrades | Overweight → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 12/05/2022 | 29.65% | B.萊利證券 | $20 → $23 | 維護 | 買 |
| 11/01/2022 | -9.81% | 摩根大通 | $18 → $16 | 維護 | 中性 |
| 11/01/2022 | 18.38% | 富國銀行 | $26 → $21 | 維護 | 超重 |
| 10/10/2022 | 1.47% | 摩根大通 | $19 → $18 | 維護 | 中性 |
| 10/06/2022 | 18.38% | 基準 | $25 → $21 | 維護 | 買 |
| 07/18/2022 | 40.92% | 基準 | $28 → $25 | 維護 | 買 |
| 06/21/2022 | 40.92% | B.萊利證券 | $30 → $25 | 維護 | 買 |
| 05/24/2022 | 40.92% | 羅森布拉特 | → $25 | 開始承保 | →購買 |
| 04/29/2022 | 29.65% | MKM合作伙伴 | $25 → $23 | 維護 | 買 |
| 10/22/2021 | 52.2% | 富國銀行 | → $27 | 開始承保 | →超重 |
| 06/02/2021 | 4.85% | 高盛 | $19.6 → $18.6 | 評級下調 | 中性→銷售 |
| 04/23/2021 | 46.56% | 韋德布什 | $22 → $26 | 升級 | 中性→表現優異 |
| 02/01/2021 | 40.92% | MKM合作伙伴 | $18 → $25 | 維護 | 買 |
| 01/25/2021 | 0.9% | 高盛 | $15.6 → $17.9 | 評級下調 | 購買→中性 |
| 07/13/2020 | 1.47% | MKM合作伙伴 | $20 → $18 | 維護 | 買 |
| 04/28/2020 | -21.08% | 基準 | → $14 | 升級 | 持有→購買 |
| 04/24/2020 | -32.36% | 韋德布什 | $25 → $12 | 評級下調 | 跑贏→中性 |
| 04/15/2020 | 12.74% | MKM合作伙伴 | $24 → $20 | 維護 | 買 |
| 03/18/2020 | 7.1% | B.萊利證券 | $26 → $19 | 維護 | 買 |
| 03/17/2020 | — | 基準 | 評級下調 | 購買→Hold | |
| 03/17/2020 | -15.45% | 摩根大通 | $22 → $15 | 評級下調 | 超重→中性 |
| 02/20/2020 | 40.92% | 韋德布什 | $22 → $25 | 維護 | 跑贏大盤 |
| 02/13/2020 | 46.56% | B.萊利證券 | $30 → $26 | 重申 | →購買 |
| 02/03/2020 | 24.01% | 韋德布什 | $28 → $22 | 維護 | 跑贏大盤 |
| 01/29/2020 | 12.74% | 基準 | $28 → $20 | 維護 | 買 |
| 11/01/2019 | — | 卡納科特·格納奇 | 升級 | 持有→購買 | |
| 02/25/2019 | — | 卡納科特·格納奇 | 評級下調 | 購買→Hold | |
| 10/26/2018 | 29.65% | 卡納科特·格納奇 | $26 → $23 | 維護 | 買 |
| 05/02/2018 | 91.66% | B.萊利證券 | $37.75 → $34 | 維護 | 買 |
| 04/27/2018 | — | 基準 | 升級 | 持有→購買 | |
| 02/28/2018 | 112.8% | B.萊利證券 | $35 → $37.75 | 維護 | 買 |
| 02/28/2018 | — | 羅斯資本 | 評級下調 | 購買→中性 | |
| 02/20/2018 | 57.84% | 摩根大通 | $27 → $28 | 維護 | 超重 |
| 02/20/2018 | 57.84% | 摩根大通 | → $28 | 假設 | 超重→超重 |
| 01/10/2018 | — | 派珀·桑德勒 | 評級下調 | 超重→中性 |
What is the target price for Imax (IMAX)?
Imax(IMAX)的目標價是多少？
The latest price target for Imax (NYSE: IMAX) was reported by B. Riley Securities on December 5, 2022. The analyst firm set a price target for $23.00 expecting IMAX to rise to within 12 months (a possible 29.65% upside). 9 analyst firms have reported ratings in the last year.
B.Riley Securities於2022年12月5日報道了Imax(紐約證券交易所代碼：IMAX)的最新目標價。這家分析公司將目標價定為23.00美元，預計IMAX將在12個月內上漲至29.65%。去年有9家分析公司公佈了評級。
What is the most recent analyst rating for Imax (IMAX)?
分析師對IMAX的最新評級是多少？
The latest analyst rating for Imax (NYSE: IMAX) was provided by B. Riley Securities, and Imax maintained their buy rating.
分析師對Imax(NYSE：IMAX)的最新評級由B.Riley Securities提供，Imax維持買入評級。
When is the next analyst rating going to be posted or updated for Imax (IMAX)?
Imax(IMAX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on December 5, 2022 so you should expect the next rating to be made available sometime around December 5, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Imax的高管和客户交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Imax的上一次評級是在2022年12月5日提交的，所以你應該預計下一次評級將在2023年12月5日左右提供。
Is the Analyst Rating Imax (IMAX) correct?
分析師評級Imax(IMAX)正確嗎？
While ratings are subjective and will change, the latest Imax (IMAX) rating was a maintained with a price target of $20.00 to $23.00. The current price Imax (IMAX) is trading at is $17.74, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Imax(IMAX)評級維持不變，目標價在20.00美元至23.00美元之間。目前Imax(IMAX)的交易價格為17.74美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。